Eisai Co., Ltd. (ESALF)
Q2 2019 Earnings Conference Call
October 30, 2019 3:00 AM ET
Company Participants
Conference Call Participants
Presentation
Unidentified Company Representative
[Call Starts Abruptly] Now, I would like to explain the consolidated financial results for the First Half of Fiscal Year 2019. The numbers shown here, all of them have exceeded our business plan. That's what I would like to report to you today. And revenue was ¥299.3 billion, a little bit smaller number than that for the last fiscal year, but during the last fiscal year, Lenvima HCC indication was approved.